2009•The Thoracic and Cardiovascular SurgeonRequires access

Immunosuppression and Long-Term Survival after Heart Transplantation

Michael Dandel

Abstract

All articles of this category Introduction Long-term outcome of patients after heart transplantation (HTx) is more dependent on benefits and side effects of immunosuppression therapy than on complications related to surgery. Moreover, drug-drug interactions of immunosuppressive agents used in different immunosuppressive regimens can impact patients' outcome. We review data on this topic and present our experience with different immunosuppression regimens obtained during more than 22 years in over 1 600 patients undergoing HTx in the German Heart Institute, Berlin.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Immunosuppression, Heart transplantation, Medicine, Transplantation, Term (time), Intensive care medicine, Immunosuppressive drug, Internal medicine